Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)

Summary

In this phase I study, escalating doses of IXAZOMIB will be combined with the POMP/D regimen.

Timeline

Start

2017-06-29

Primary completion

2018-02-13

Completion

2018-02-13

Drugs

Indications